Finnadvance has developed microfluidic devices for in-vitro microvascular network generation.
Finnadvance has raised $1.3M in total funding. The most recent round was Seed. The last funding was announced in April 2022.
Finnadvance's investors include Voima Ventures, Icebreaker.vc, Athensmed, Takoa Invest, Leena Niemistö.
Finnadvance is headquartered in Oulu, Finland.
Finnadvance has developed microfluidic devices for in-vitro microvascular network generation.
Finnadvance is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Finnadvance — Funding & Investors." VCBacked, April 8, 2022, https://www.vcbacked.co/company/finnadvance. Accessed October 1, 2026.
VCBacked. (2022). Finnadvance — Funding & Investors. Retrieved October 1, 2026, from https://www.vcbacked.co/company/finnadvance
{{cite web |title=Finnadvance — Funding & Investors |url=https://www.vcbacked.co/company/finnadvance |website=VCBacked |access-date=October 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated